SG127720A1 - Fibrinolytically active polypeptide - Google Patents

Fibrinolytically active polypeptide

Info

Publication number
SG127720A1
SG127720A1 SG200401889A SG200401889A SG127720A1 SG 127720 A1 SG127720 A1 SG 127720A1 SG 200401889 A SG200401889 A SG 200401889A SG 200401889 A SG200401889 A SG 200401889A SG 127720 A1 SG127720 A1 SG 127720A1
Authority
SG
Singapore
Prior art keywords
active polypeptide
fibrinolytically active
fibrinolytically
vivo
useful
Prior art date
Application number
SG200401889A
Other languages
English (en)
Inventor
Charles Thomas Boone
Li Huimin
Benjamin Michael Mann
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of SG127720A1 publication Critical patent/SG127720A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6418—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals from snakes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG200401889A 1999-10-01 2000-09-29 Fibrinolytically active polypeptide SG127720A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/411,329 US6261820B1 (en) 1999-10-01 1999-10-01 Fibronolytically active polypeptide

Publications (1)

Publication Number Publication Date
SG127720A1 true SG127720A1 (en) 2006-12-29

Family

ID=23628486

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200401889A SG127720A1 (en) 1999-10-01 2000-09-29 Fibrinolytically active polypeptide

Country Status (29)

Country Link
US (4) US6261820B1 (hu)
EP (2) EP1224298B1 (hu)
JP (1) JP2003511034A (hu)
KR (2) KR100700753B1 (hu)
CN (2) CN101230340A (hu)
AT (1) ATE292180T1 (hu)
AU (1) AU767827B2 (hu)
BG (1) BG106577A (hu)
BR (1) BR0014414A (hu)
CA (1) CA2386185A1 (hu)
CZ (1) CZ298502B6 (hu)
DE (1) DE60019147T2 (hu)
DK (1) DK1224298T3 (hu)
EA (2) EA006487B1 (hu)
ES (1) ES2240167T3 (hu)
HK (1) HK1049351B (hu)
HU (1) HUP0202650A3 (hu)
IL (1) IL148787A0 (hu)
MX (1) MXPA02003126A (hu)
NO (1) NO20021501L (hu)
NZ (1) NZ517951A (hu)
PL (1) PL355017A1 (hu)
PT (1) PT1224298E (hu)
RS (1) RS20060033A (hu)
SG (1) SG127720A1 (hu)
SK (1) SK4232002A3 (hu)
WO (1) WO2001025445A1 (hu)
YU (2) YU22502A (hu)
ZA (1) ZA200202206B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261820B1 (en) 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
US6440414B1 (en) 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6455269B1 (en) * 1999-12-17 2002-09-24 Amgen, Inc. Method for localized administration of fibrinolytic metalloproteinases
US7033776B2 (en) 1999-12-17 2006-04-25 Amgen Inc. Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
US6523647B2 (en) * 2001-05-21 2003-02-25 Hydro Mobile Inc. Elevating platform assembly
EP1482882B1 (en) * 2002-02-11 2011-09-14 Gold-T Tech, Inc. Implantable device for preventing thrombus formation
US7016409B2 (en) * 2003-11-12 2006-03-21 Sony Corporation Apparatus and method for use in providing dynamic bit rate encoding
ES2239532B1 (es) * 2004-02-06 2006-11-01 Proyecto De Biomedicina Cima S.L. Metodo para evaluar el riesgo y la predisposicion a desarrollar una patologia relacionada con la presencia de autoanticuerpos frente a epcr.
US20070141625A1 (en) * 2005-02-03 2007-06-21 Santos Jose H Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies
WO2007092820A2 (en) 2006-02-03 2007-08-16 Lazarus Effect, Inc. Methods and devices for restoring blood flow within blocked vasculature
WO2010102307A1 (en) 2009-03-06 2010-09-10 Lazarus Effect, Inc. Retrieval systems and methods for use thereof
WO2011056872A2 (en) 2009-11-03 2011-05-12 Gen9, Inc. Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
JP2017532024A (ja) 2014-09-09 2017-11-02 ザ・ブロード・インスティテュート・インコーポレイテッド コンポジット単一細胞核酸分析のための液滴ベースの方法および機器
US10456560B2 (en) 2015-02-11 2019-10-29 Covidien Lp Expandable tip medical devices and methods
WO2016145409A1 (en) 2015-03-11 2016-09-15 The Broad Institute, Inc. Genotype and phenotype coupling
WO2017075265A1 (en) 2015-10-28 2017-05-04 The Broad Institute, Inc. Multiplex analysis of single cell constituents
WO2017075297A1 (en) 2015-10-28 2017-05-04 The Broad Institute Inc. High-throughput dynamic reagent delivery system
US11072816B2 (en) 2017-05-03 2021-07-27 The Broad Institute, Inc. Single-cell proteomic assay using aptamers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692406A (en) * 1983-08-25 1987-09-08 Boehringer Mannheim Gmbh Process and a reagent for the simultaneous determination of fibrinogen and fibrinogen fission products in plasma
EP0323722A1 (en) * 1987-12-18 1989-07-12 Chiron Corporation Compositions and method for recombinant production of crotalidus venom fibrolase
WO1999029838A1 (en) * 1997-12-09 1999-06-17 Bristol-Myers Squibb Company Fibrinogen-converting enzyme hybrids

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310133A2 (fr) 1975-05-05 1976-12-03 Fabre Sa Pierre Nouveau medicament comportant un activateur du plasminogene perfectionne
US4447236A (en) 1982-02-05 1984-05-08 Cordis Corporation Infusion catheter system
US4610879A (en) 1984-01-06 1986-09-09 University Of Southern California Fibrinolytic enzyme from snake vernom
CA1237482A (en) 1984-03-09 1988-05-31 Frank B. Stiles Catheter for effecting removal of obstructions from a biological duct
US4755167A (en) 1984-04-10 1988-07-05 Research Corporation In vivo method for distribution and stirring of therapeutic agents
US4885242A (en) 1984-10-30 1989-12-05 Phillips Petroleum Company Genes from pichia histidine pathway and uses thereof
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
WO1990007352A1 (en) 1989-01-04 1990-07-12 Boston Scientific Corporation Angioplasty catheter
US5222941A (en) 1990-01-12 1993-06-29 Don Michael T Anthony Method of dissolving an obstruction in a vessel
ATE220721T1 (de) * 1990-01-16 2002-08-15 Ct Ingenieria Genetica Biotech Verfahren zur expression heterologischer gene in der hefe pichia pastoris, expressionsvektoren und transformierte mikroorganismen
US5709676A (en) 1990-02-14 1998-01-20 Alt; Eckhard Synergistic treatment of stenosed blood vessels using shock waves and dissolving medication
US5250034A (en) 1990-09-17 1993-10-05 E-Z-Em, Inc. Pressure responsive valve catheter
US5167628A (en) 1991-05-02 1992-12-01 Boyles Paul W Aortic balloon catheter assembly for indirect infusion of the coronary arteries
US5380273A (en) 1992-05-19 1995-01-10 Dubrul; Will R. Vibrating catheter
EP0624642B1 (en) 1993-05-12 1999-01-20 Indian Council For Medical Research Novel thrombolytic agent, process for preparing same and its use for the preparation of a thrombi dissolving medicament
US5370653A (en) 1993-07-22 1994-12-06 Micro Therapeutics, Inc. Thrombectomy method and apparatus
JP3537440B2 (ja) 1993-12-17 2004-06-14 持田製薬株式会社 可溶性トロンボモジュリンを長期保存安定化させる方法
US5626564A (en) 1995-03-31 1997-05-06 Creighton University Adjustable sideholes catheter
US5830468A (en) 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
US6020181A (en) 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
US5741779A (en) 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
DE69734060T2 (de) 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
US5951981A (en) * 1996-12-02 1999-09-14 Diatide, Inc. Thrombolytic agents with antithrombotic activity
US6413760B1 (en) * 1997-04-15 2002-07-02 Genetics Institute, Inc. Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof
US6261820B1 (en) 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
US6440414B1 (en) 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6455269B1 (en) 1999-12-17 2002-09-24 Amgen, Inc. Method for localized administration of fibrinolytic metalloproteinases
US20020081685A1 (en) 2000-08-03 2002-06-27 Fox Brian A. Disintegrin homologs, ZSNK10, ZSNK11, and ZSNK12

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692406A (en) * 1983-08-25 1987-09-08 Boehringer Mannheim Gmbh Process and a reagent for the simultaneous determination of fibrinogen and fibrinogen fission products in plasma
EP0323722A1 (en) * 1987-12-18 1989-07-12 Chiron Corporation Compositions and method for recombinant production of crotalidus venom fibrolase
WO1999029838A1 (en) * 1997-12-09 1999-06-17 Bristol-Myers Squibb Company Fibrinogen-converting enzyme hybrids

Also Published As

Publication number Publication date
IL148787A0 (en) 2002-09-12
YU22502A (sh) 2005-07-19
YU59604A (sh) 2005-11-28
DE60019147D1 (en) 2005-05-04
BR0014414A (pt) 2002-06-11
NO20021501L (no) 2002-05-31
US20020058322A1 (en) 2002-05-16
US6617145B2 (en) 2003-09-09
NO20021501D0 (no) 2002-03-26
EP1224298B1 (en) 2005-03-30
EA005944B1 (ru) 2005-08-25
SK4232002A3 (en) 2003-09-11
CA2386185A1 (en) 2001-04-12
KR100711312B1 (ko) 2007-04-27
HK1049351A1 (en) 2003-05-09
US20080058256A1 (en) 2008-03-06
KR20060114034A (ko) 2006-11-03
EP1224298A1 (en) 2002-07-24
DE60019147T2 (de) 2006-05-11
US6261820B1 (en) 2001-07-17
AU767827B2 (en) 2003-11-27
ZA200202206B (en) 2002-12-24
CN100357430C (zh) 2007-12-26
US20030186422A1 (en) 2003-10-02
CZ20021034A3 (cs) 2003-06-18
JP2003511034A (ja) 2003-03-25
EP1605049A2 (en) 2005-12-14
MXPA02003126A (es) 2002-09-30
CZ298502B6 (cs) 2007-10-24
BG106577A (bg) 2003-04-30
KR20020047208A (ko) 2002-06-21
EA006487B1 (ru) 2005-12-29
EA200400290A1 (ru) 2005-02-24
EP1605049A3 (en) 2006-12-13
ES2240167T3 (es) 2005-10-16
HUP0202650A2 (hu) 2002-12-28
PL355017A1 (en) 2004-03-22
EA200200410A1 (ru) 2002-10-31
ATE292180T1 (de) 2005-04-15
US7195903B2 (en) 2007-03-27
NZ517951A (en) 2004-02-27
CN1402788A (zh) 2003-03-12
KR100700753B1 (ko) 2007-03-28
CN101230340A (zh) 2008-07-30
HUP0202650A3 (en) 2005-01-28
HK1049351B (zh) 2005-07-29
DK1224298T3 (da) 2005-05-30
RS20060033A (sr) 2006-12-15
PT1224298E (pt) 2005-06-30
WO2001025445A1 (en) 2001-04-12
AU7625400A (en) 2001-05-10

Similar Documents

Publication Publication Date Title
IL148787A0 (en) Fibrinolytically active polypeptide
DE69432592D1 (de) Mutanten der pro-urokinase
DE10199044I1 (de) Varianten des Gewebeplasminogen-Aktivators mit verbesserter Therapeutischer Wirkung
PT1232254E (pt) Processo para a produção de uma composição de plasmina acidificada reversivelmente inactiva
WO2001004146A3 (en) Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof
AU7951798A (en) Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
ZA927360B (en) Improved tissue glue prepared by using cryoprecipitate
WO1988005081A3 (en) Novel plasminogen activator
ATE144283T1 (de) Ergiebige herstellung von protease-mutanten
ATE103332T1 (de) Modifizierter gewebeplasminogenaktivator.
Rudenskaya et al. Studying in vitro fibrinolytic and thrombolytic properties of thiol-dependent serine proteinase from Thermoactinomyces vulgaris.
ES2067326T3 (es) Variante especifica de activador de plasminogeno tisular.
DE59001558D1 (de) Thrombolytisch wirkendes kombinationspraeparat.